Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

Biotechnology may be one relatively overlooked sector ... Firefly Neuroscience Inc (NASDAQ:AIFF) has developed an AI-driven ...

ADC Therapeutics has stopped development of lead solid tumor candidate ADCT-601. The biotech axed the AXL-directed ...

About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 ...

Still, you largely own biotech stocks for the promise of their research and development (R&D) pipeline and the company's ...

According to McKinsey, one biotech platform category of considerable investor interest is 'new delivery methods that can send novel therapies to the entire affected tissue precisely and safely.' ...

Archon Biosciences, a biotech startup putting AI to work designing novel biomolecules, has just emerged from stealth with an ...

Last year, biotech shutdowns spiked. Thankfully, 2024’s numbers are a little lower, dropping from the 27 closures in 2023 to 22 this year.

The acquisition of Aliada Therapeutics gives AbbVie access to a Phase I anti-amyloid antibody as well as the biotech’s novel ...

Twist Bioscience focuses on synthetic DNA manufacturing, leveraging its proprietary silicon-based platform. Find out why I'm ...

Nautilus Biotechnolgy, Inc. ( ($NAUT) ) has realeased its Q3 earnings. Here is a breakdown of the information Nautilus ...

The firm had received notice last year that it was out of compliance with a requirement to maintain a minimum $15 million market value of publicly held shares.